Skip to main content
. Author manuscript; available in PMC: 2017 Aug 21.
Published in final edited form as: Clin Cancer Res. 2017 Apr 26;23(16):4919–4928. doi: 10.1158/1078-0432.CCR-16-2656

Figure 3.

Figure 3

Mosaic plots representing activation of AKT (S473) and downstream substrates mTOR (S2448), S6RP (S235/236), and 4EBP1 (S65) across 154 metastatic breast cancer. Proportion of positive patients is plotted along with the site of metastasis. P values were calculated using a Fisher exact test.